A citation-based method for searching scientific literature

Thomas F Varley, Robin Carhart-Harris, Leor Roseman, David K Menon, Emmanuel A Stamatakis. Neuroimage 2020
Times Cited: 17







List of co-cited articles
275 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs.
Robin L Carhart-Harris, Robert Leech, Peter J Hellyer, Murray Shanahan, Amanda Feilding, Enzo Tagliazucchi, Dante R Chialvo, David Nutt. Front Hum Neurosci 2014
322
70

Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin.
Robin L Carhart-Harris, David Erritzoe, Tim Williams, James M Stone, Laurence J Reed, Alessandro Colasanti, Robin J Tyacke, Robert Leech, Andrea L Malizia, Kevin Murphy,[...]. Proc Natl Acad Sci U S A 2012
391
58


Dynamical exploration of the repertoire of brain networks at rest is modulated by psilocybin.
Louis-David Lord, Paul Expert, Selen Atasoy, Leor Roseman, Kristina Rapuano, Renaud Lambiotte, David J Nutt, Gustavo Deco, Robin L Carhart-Harris, Morten L Kringelbach,[...]. Neuroimage 2019
44
47

Psychedelics and the essential importance of context.
Robin L Carhart-Harris, Leor Roseman, Eline Haijen, David Erritzoe, Rosalind Watts, Igor Branchi, Mendel Kaelen. J Psychopharmacol 2018
139
47

Psychedelics.
David E Nichols. Pharmacol Rev 2016
453
47

Increased Global Functional Connectivity Correlates with LSD-Induced Ego Dissolution.
Enzo Tagliazucchi, Leor Roseman, Mendel Kaelen, Csaba Orban, Suresh D Muthukumaraswamy, Kevin Murphy, Helmut Laufs, Robert Leech, John McGonigle, Nicolas Crossley,[...]. Curr Biol 2016
158
47

Neural correlates of the LSD experience revealed by multimodal neuroimaging.
Robin L Carhart-Harris, Suresh Muthukumaraswamy, Leor Roseman, Mendel Kaelen, Wouter Droog, Kevin Murphy, Enzo Tagliazucchi, Eduardo E Schenberg, Timothy Nest, Csaba Orban,[...]. Proc Natl Acad Sci U S A 2016
275
47

The entropic brain - revisited.
Robin L Carhart-Harris. Neuropharmacology 2018
104
47

Enhanced repertoire of brain dynamical states during the psychedelic experience.
Enzo Tagliazucchi, Robin Carhart-Harris, Robert Leech, David Nutt, Dante R Chialvo. Hum Brain Mapp 2014
154
47

Psychedelics Promote Structural and Functional Neural Plasticity.
Calvin Ly, Alexandra C Greb, Lindsay P Cameron, Jonathan M Wong, Eden V Barragan, Paige C Wilson, Kyle F Burbach, Sina Soltanzadeh Zarandi, Alexander Sood, Michael R Paddy,[...]. Cell Rep 2018
248
41

Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study.
Robin L Carhart-Harris, Mark Bolstridge, James Rucker, Camilla M J Day, David Erritzoe, Mendel Kaelen, Michael Bloomfield, James A Rickard, Ben Forbes, Amanda Feilding,[...]. Lancet Psychiatry 2016
461
41

Emotions and brain function are altered up to one month after a single high dose of psilocybin.
Frederick S Barrett, Manoj K Doss, Nathan D Sepeda, James J Pekar, Roland R Griffiths. Sci Rep 2020
62
41

LSD-induced entropic brain activity predicts subsequent personality change.
A V Lebedev, M Kaelen, M Lövdén, J Nilsson, A Feilding, D J Nutt, R L Carhart-Harris. Hum Brain Mapp 2016
97
41

Connectome-harmonic decomposition of human brain activity reveals dynamical repertoire re-organization under LSD.
Selen Atasoy, Leor Roseman, Mendel Kaelen, Morten L Kringelbach, Gustavo Deco, Robin L Carhart-Harris. Sci Rep 2017
61
41

Increased spontaneous MEG signal diversity for psychoactive doses of ketamine, LSD and psilocybin.
Michael M Schartner, Robin L Carhart-Harris, Adam B Barrett, Anil K Seth, Suresh D Muthukumaraswamy. Sci Rep 2017
119
41

Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial.
Roland R Griffiths, Matthew W Johnson, Michael A Carducci, Annie Umbricht, William A Richards, Brian D Richards, Mary P Cosimano, Margaret A Klinedinst. J Psychopharmacol 2016
527
35


Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin.
N L Mason, K P C Kuypers, F Müller, J Reckweg, D H Y Tse, S W Toennes, N R P W Hutten, J F A Jansen, P Stiers, A Feilding,[...]. Neuropsychopharmacology 2020
39
35

Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial.
Stephen Ross, Anthony Bossis, Jeffrey Guss, Gabrielle Agin-Liebes, Tara Malone, Barry Cohen, Sarah E Mennenga, Alexander Belser, Krystallia Kalliontzi, James Babb,[...]. J Psychopharmacol 2016
440
35

The paradoxical psychological effects of lysergic acid diethylamide (LSD).
R L Carhart-Harris, M Kaelen, M Bolstridge, T M Williams, L T Williams, R Underwood, A Feilding, D J Nutt. Psychol Med 2016
134
35

Homological scaffolds of brain functional networks.
G Petri, P Expert, F Turkheimer, R Carhart-Harris, D Nutt, P J Hellyer, F Vaccarino. J R Soc Interface 2014
150
35

Psilocybin-assisted mindfulness training modulates self-consciousness and brain default mode network connectivity with lasting effects.
Lukasz Smigielski, Milan Scheidegger, Michael Kometer, Franz X Vollenweider. Neuroimage 2019
54
29

Psilocybin Induces Time-Dependent Changes in Global Functional Connectivity.
Katrin H Preller, Patricia Duerler, Joshua B Burt, Jie Lisa Ji, Brendan Adkinson, Philipp Stämpfli, Erich Seifritz, Grega Repovš, John H Krystal, John D Murray,[...]. Biol Psychiatry 2020
31
29

Psilocybin with psychological support for treatment-resistant depression: six-month follow-up.
R L Carhart-Harris, M Bolstridge, C M J Day, J Rucker, R Watts, D E Erritzoe, M Kaelen, B Giribaldi, M Bloomfield, S Pilling,[...]. Psychopharmacology (Berl) 2018
235
29

Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study.
Michael P Bogenschutz, Alyssa A Forcehimes, Jessica A Pommy, Claire E Wilcox, P C R Barbosa, Rick J Strassman. J Psychopharmacol 2015
364
29

The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future.
Robin L Carhart-Harris, Guy M Goodwin. Neuropsychopharmacology 2017
154
29

Trial of Psilocybin versus Escitalopram for Depression.
Robin Carhart-Harris, Bruna Giribaldi, Rosalind Watts, Michelle Baker-Jones, Ashleigh Murphy-Beiner, Roberta Murphy, Jonny Martell, Allan Blemings, David Erritzoe, David J Nutt. N Engl J Med 2021
142
29

Psilocybin biases facial recognition, goal-directed behavior, and mood state toward positive relative to negative emotions through different serotonergic subreceptors.
Michael Kometer, André Schmidt, Rosilla Bachmann, Erich Studerus, Erich Seifritz, Franz X Vollenweider. Biol Psychiatry 2012
136
29

Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action.
F X Vollenweider, M F Vollenweider-Scherpenhuyzen, A Bäbler, H Vogel, D Hell. Neuroreport 1998
479
29

LSD alters dynamic integration and segregation in the human brain.
Andrea I Luppi, Robin L Carhart-Harris, Leor Roseman, Ioannis Pappas, David K Menon, Emmanuel A Stamatakis. Neuroimage 2021
24
29

The Fabric of Meaning and Subjective Effects in LSD-Induced States Depend on Serotonin 2A Receptor Activation.
Katrin H Preller, Marcus Herdener, Thomas Pokorny, Amanda Planzer, Rainer Kraehenmann, Philipp Stämpfli, Matthias E Liechti, Erich Seifritz, Franz X Vollenweider. Curr Biol 2017
157
23

Serotonin and brain function: a tale of two receptors.
R L Carhart-Harris, D J Nutt. J Psychopharmacol 2017
218
23

Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer.
Charles S Grob, Alicia L Danforth, Gurpreet S Chopra, Marycie Hagerty, Charles R McKay, Adam L Halberstadt, George R Greer. Arch Gen Psychiatry 2011
426
23

Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder.
Francisco A Moreno, Christopher B Wiegand, E Keolani Taitano, Pedro L Delgado. J Clin Psychiatry 2006
240
23

Psychedelic Psychiatry's Brave New World.
David Nutt, David Erritzoe, Robin Carhart-Harris. Cell 2020
70
23

Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior.
Javier González-Maeso, Noelia V Weisstaub, Mingming Zhou, Pokman Chan, Lidija Ivic, Rosalind Ang, Alena Lira, Maria Bradley-Moore, Yongchao Ge, Qiang Zhou,[...]. Neuron 2007
461
23

Psilocybin acutely alters the functional connectivity of the claustrum with brain networks that support perception, memory, and attention.
Frederick S Barrett, Samuel R Krimmel, Roland R Griffiths, David A Seminowicz, Brian N Mathur. Neuroimage 2020
29
23

Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function.
Matthew W Johnson, Peter S Hendricks, Frederick S Barrett, Roland R Griffiths. Pharmacol Ther 2019
101
23

Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors.
Roland R Griffiths, Matthew W Johnson, William A Richards, Brian D Richards, Robert Jesse, Katherine A MacLean, Frederick S Barrett, Mary P Cosimano, Maggie A Klinedinst. J Psychopharmacol 2018
115
23

Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies.
Erich Studerus, Michael Kometer, Felix Hasler, Franz X Vollenweider. J Psychopharmacol 2011
187
23

A single psilocybin dose is associated with long-term increased mindfulness, preceded by a proportional change in neocortical 5-HT2A receptor binding.
Martin Korsbak Madsen, Patrick MacDonald Fisher, Dea Siggaard Stenbæk, Sara Kristiansen, Daniel Burmester, Szabolcs Lehel, Tomas Páleníček, Martin Kuchař, Claus Svarer, Brice Ozenne,[...]. Eur Neuropsychopharmacol 2020
37
23

Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness.
Katherine A MacLean, Matthew W Johnson, Roland R Griffiths. J Psychopharmacol 2011
277
23

Effect of Psilocybin on Empathy and Moral Decision-Making.
Thomas Pokorny, Katrin H Preller, Michael Kometer, Isabel Dziobek, Franz X Vollenweider. Int J Neuropsychopharmacol 2017
61
23

Human hallucinogen research: guidelines for safety.
Mw Johnson, Wa Richards, Rr Griffiths. J Psychopharmacol 2008
333
23

Shannon entropy of brain functional complex networks under the influence of the psychedelic Ayahuasca.
A Viol, Fernanda Palhano-Fontes, Heloisa Onias, Draulio B de Araujo, G M Viswanathan. Sci Rep 2017
42
23

Altered network hub connectivity after acute LSD administration.
Felix Müller, Patrick C Dolder, André Schmidt, Matthias E Liechti, Stefan Borgwardt. Neuroimage Clin 2018
43
23

The effects of psilocybin and MDMA on between-network resting state functional connectivity in healthy volunteers.
Leor Roseman, Robert Leech, Amanda Feilding, David J Nutt, Robin L Carhart-Harris. Front Hum Neurosci 2014
93
23

Human brain networks function in connectome-specific harmonic waves.
Selen Atasoy, Isaac Donnelly, Joel Pearson. Nat Commun 2016
122
23

Unifying Theories of Psychedelic Drug Effects.
Link R Swanson. Front Pharmacol 2018
32
23


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.